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Protein–protein interactionProhibitin (PHB or PHB1) is an evolutionarily conserved ubiquitously expressed multifunctional protein
and is present in various cellular compartments. Phosphorylation of PHB has been suggested as one of the
potential mechanisms in the regulation of its various functions however exact sites of phosphorylation
remain to be determined. To better understand the functional relevance of phosphorylation of PHB, we
have explored the potential sites of phosphorylation using combination of approaches including
phosphoamino speciﬁc immunoblotting, proteolysis, two-dimensional gel electrophoresis, phosphoamino
acid analysis and site-directed mutagenesis techniques and report that tyrosine 114 (Tyr114) in PHB is
phosphorylated in response to insulin stimulation. In addition, using active insulin receptor (IR) and
synthetic biotinylated PHB peptide (PHB107–121) we have shown that IR also phosphorylates Tyr114 in an in
vitro kinase assay. Phosphorylation of PHB at Tyr114 was conﬁrmed by immunoblotting using anti-
phosphoTyr114 speciﬁc antibody. Furthermore, we demonstrate that SH2 domain containing tyrosine
phosphatase-1 (Shp1) co-immunoprecipitate with PHB antiserum after insulin induced phosphorylation of
PHB. Biotinylated-PHB107–121 peptide phosphorylated at Tyr114 was also able to pull down Shp1 in pull
down assays. Non-phosphorylated PHB107–121 peptide, corresponding PHB2121–135 peptide and Tyr114Phe
mutant-PHB fail to pull down Shp1. In summary, we have identiﬁed Tyr114 in PHB as an important site of
phosphorylation and phosphorylation at this residue creates a binding site for Shp1 both in vivo and
in vitro.© 2009 Elsevier B.V. All rights reserved.1. IntroductionProhibitin (PHB or PHB1) and its homolog PHB2 (also known as
REA) are evolutionarily conserved and ubiquitously expressed how-
ever poorly characterized protein that is present in various cellular
compartments and are involved in diverse cellular processes such as
cell proliferation, differentiation, apoptosis and cell signaling [1]. PHB
and PHB2 belongs to a family of proteins characterized by the
presence of a prohibitin-like domain (PHB domain) also known as
band-7 family of proteins, and are known to associate with lipid rafts
in the plasmamembrane [2]. PHB has also been reported to be present
in associationwith IgM receptor in lymphocytes [3], on the cell surface
of endothelial cells in the vasculature of white adipose tissue [4], on
the plasmamembrane of Caco-2 cells [5] and 3T3-L1 adipocytes [6]. In
Caco-2 and 3T3-L1 cells, PHB was found enriched in lipid rafts, sites
that are believed to regulate many intracellular signaling events [5–6].
In recent years, there has been an increased emphasis on the role of
lipid rafts (also known as membrane microdomains) in the compart-
mentalization of insulin signaling [7]. Lipid rafts are speciﬁc regions in
the plasma membrane that are enriched in cholesterol and lipids withsearch Centre, 715 McDermot
629; fax: +1 204 789 3940.
.
ll rights reserved.saturated fatty acids and that are able to move protein molecules
between cellular compartments [8]. Recent studies suggest that some
speciﬁc cytoplasmic proteins are translocated into lipid rafts, and that
this process may be important for signal transduction [8]. Phosphor-
ylation and other post-translational modiﬁcations play an important
role in this process [9]. PHB from various cell/tissue types under
different experimental conditions has been reported to migrate
differently after iso-electric focusing which is assumed to be due to
phosphorylation [10–12].
Phosphorylation is a fundamental post-translational modiﬁcation
that is used to regulate the function, localization and binding
speciﬁcity of the proteins [13,14]. However, abnormal protein
phosphorylation can lead to diabetes, cancer and other diseases.
Thus, identiﬁcation of phosphorylation status of protein is important
with respect to evaluating biological and pathological processes. PHB
isoforms described so far are thought to be due to phosphorylation
[10–12] and phosphorylation of PHB has been shown to be important
in plants [15]. It is possible that phosphorylation of PHB is equally
important in animals and thus, identiﬁcation of phosphorylation sites
and kinase involved may hold potential to better understand its
function. Therefore, in the present study we have explored the
potential phosphorylation sites in PHB and report that Tyr114 in PHB is
phosphorylated in response to insulin stimulation and that phosphor-
ylation at this residue creates a binding site for SH2 domain containing
1373S.R. Ande et al. / Biochimica et Biophysica Acta 1793 (2009) 1372–1378tyrosine phosphatase-1 (Shp1). To our knowledge this is the ﬁrst
report of identiﬁcation of tyrosine phosphorylation in PHB and its
interaction with Shp1 in a phosphorylation dependent manner.
2. Materials and methods
2.1. Reagents
Recombinant insulin receptor (IR) catalytic domainwas purchased
from Upstate Biotechnology (Lake Placid, NY, USA) and anti-PHB
antibodies from NeoMarkers (Fremont, CA) and Cell Signaling (MA,
USA). Protein G-agarose was obtained from Pierce (Rockford, IL, USA).
Insulin, phosphoamino speciﬁc antibodies, streptavidin-HRP, strepta-
vidin-agarose and all other reagents were obtained from Sigma-
Aldrich Canada (Oakville, ON) unless otherwise stated. C2C12 and
MCF-7 cells were obtained from the American Type Tissue Collection
(Manassas, VA) and cell culture reagents were from Invitrogen
(Burlington, ON, Canada). Phospho-Akt kit was obtained from Cell
Signaling Technology (Danvers, MA).
2.2. Cell culture
C2C12 andMCF-7 cells were grown in Dulbeccos's modiﬁed Eagle's
medium supplemented with 10% fetal calf serum at 37 °C with 5% CO2
in humidiﬁed atmosphere. After 72 h in culture, the medium was
exchanged for serum free media and cells were serum starved for 6 h.
Subsequently cells were treated with insulin (100 nM) for 20 min and
ﬁnally cell lysates were prepared in 50 mM Tris–HCl buffer (pH 7.5,
120 mM NaCl, 0.5% Nonidet P40, 100 mM NaF, 200 mM NaVO5, 1 mM
phenylmethylsulfonyl ﬂuoride, 10 μg/ml leupeptin, and 10 μg/ml
aprotinin).
2.3. Site directed mutagenesis
The pCMV6-XL5 vector containing PHB clone was obtained from
Origene Technologies, USA. Tyrosine 114 to phenylalanine
(Tyr114Phe) mutant-PHB was made using site-directed mutagenesis
kit (Stratagene, USA) following the manufacturer's instructions. The
following primers were used for generating mutant-PHB (forward: 5′
CAGCATCGGAGAGGACTTTGATGAGCGTGTGC 3′ and reverse: 5′ GCA-
CACGCTCATCAAAGTCCTCTCCGATGCTG 3′). Authenticity of all con-
structs was conﬁrmed by DNA sequencing. Transfections were
performed using lipofectamine (Invitrogen), according to the manu-
facturer's protocol.
2.4. Immunoprecipitation and Western blot
To 1 ml of cell lysate,10 μl of mouse monoclonal anti-PHB antibody
was added and incubated overnight on a rotating device at 4 °C. At the
end of the incubation, 25 μl of Dynabeads Protein G (Invitrogen, USA)
suspension was added to each tube and further incubated for 2 h.
Subsequently, pellets were washed (5×) in ice cold PBS. Immunopre-
cipitated proteins were separated on 11% SDS-PAGE and transferred to
nitrocellulose membrane for Western blotting. Membranes were
blocked in 5% milk, incubated with phosphoamino speciﬁc mono-
clonal antibodies (1:7500) or anti-pTyr114 speciﬁc antibody (1:1000)
for 2 h at RT. After incubation, membranes were washed (3×) in TBST
(10 mM Tris, 150 mM NaCl, 0.05% Tween 20, pH 8.0) for 15 min each
and incubated with secondary antibody-HRP conjugate (1:5000) for
1 h at RT. Membranes were washed (3×) in TBST for 15 min each and
subsequently analyzed with ECL (Amersham, Germany). After strip-
ping membranes were reprobed with anti-PHB antibody to conﬁrm
that the identiﬁed band was PHB. A parallel gel was stained in
Coomassie blue and PHB corresponding band was excised and
processed for proteolysis by endopeptidase Lys-C.2.5. Recombinant protein and peptides
Recombinant human His-tagged PHB (His-PHB) expressed in
Escherichia coli was obtained from AmProx Inc. (Carlsbad, CA, USA).
It is greater than 90% pure and appears as a single band on Coomassie
blue stained gels. It was supplied by the manufacturer in solubilized
form and it contained 50% glycerol to facilitate proper folding and
to prevent freeze-thaw damage. Custom made PHB107–121 and
PHB2121–135 peptides were chemically synthesized as 15mer peptide
amidated at C-terminus and biotinylated at N-terminus. The correct
peptides were obtained in greater than 90% yield and were homo-
geneous after puriﬁcation as conﬁrmed by mass and analytical HPLC.
2.6. Generation of anti-phospho-Tyr114 (anti-pTyr114) antibody
The anti-pTyr114 rabbit phosphospeciﬁc antibody against PHB
peptide Ac-IGED[pY]DERVLPSIC-amide phosphorylated at tyrosine
114 residue was custom prepared and afﬁnity puriﬁed by 21st Century
Biochemicals (Marlboro, MA). In brief, two rabbits were immunized
with the PHB phosphopeptide. The terminal bleeds were depleted
over a non-phosphopeptide column and then subjected to two
successive puriﬁcations over a phosphopeptide column. Enzyme-
linked immunosorbent assay analysis showed a N1000-fold prefer-
ence for phosphorylated peptide over non-phosphopeptide.
2.7. In vitro phosphorylation assay
Recombinant His-PHB and PHB107–121 synthetic peptide were
incubated with 20 ng of recombinant active insulin receptor (IR) in
kinase buffer (50 mM Tris–HCl, pH 7.5, 10 mM MgCl2, 50 μl ATP,
60 μCi/ml [γ 32P]ATP) for 30 min at 30 °C. The phosphorylation
reaction was stopped by addition of SDS-PAGE sample buffer, boiled
for 5 min and analyzed on 16% SDS-PAGE. Subsequently, gels were
dried and processed for autoradiography. To determine the stoichio-
metry of PHB protein and peptide phosphorylation, the reaction was
carried out in a ﬁnal volume of 500 μl containing 10 μg of substrate and
500 ng of IR. Aliquots were removed at various time points, mixed
with sample buffer, and boiled for 5 min . Phosphorylated protein/
peptides were separated on SDS-PAGE, and gels were stained with
Coomassie blue. Bands corresponding to phosphorylated PHB protein/
peptides were excised and their radioactivitymeasured. For pull down
assays peptides were immobilized on streptavidin-agarose and
phosphorylated as described above using cold ATP only. PHB peptide
mediated pulled down proteins were separated by SDS-PAGE,
transferred to nitrocellulose membranes and processed for Western
blot as described above.
2.8. Proteolysis of phosphorylated PHB by Lys-C
In gel digestion of phosphorylated PHB excised bands was
performed overnight in 100 mM NH4HCO3 (pH 8.5) using a ratio of
1/20 of enzyme to substrate. Proteolysed PHB was extracted from the
gel, lyophilized as described earlier [16], resuspended in 50 mM Tris
buffer (pH 7.4) and subsequently analyzed by one- and two-
dimensional gel electrophoresis.
2.9. Two-dimensional gel electrophoresis
Two-dimensional gel electrophoresis of the proteolysed PHB was
performed using Mini-PROTEAN II tube cell (Bio-Rad, USA). Gel tubes
were pre-electrophoresed by running at 200 V for 10 min, 300 V for
15 min and 400 V for 15 min. Iso-electric focusing was done at 400 V
for 6 h using urea-acrylamide gel (9 M urea and 4% acrylamide (total
monomer)) containing 1.6% Bio-Lyte 5/7 ampholyte and 0.4% Bio-Lyte
3/10 ampholyte. After ﬁrst dimension run was complete, gels were
extruded from the capillaries and kept in SDS sample equilibration
Fig. 1. Phosphorylation of PHB at tyrosine residues. (A) PHB was immunoprecipitated
(IP) from C2C12 cells after treatment with insulin (100 nM) for 20 min and
subsequently analyzed by immunoblotting (IB) with anti-phosphotyrosine (upper
panel) and the same membrane was reprobed with anti-PHB antibody (lower panel).
(B) Phosphoamino acid analysis of PHB from C2C12 cells in response to insulin after 32P-
orthophosphate metabolic labeling. Phosphoamino acid standards were detected by
ninhydrin and PHB phosphoamino acid was detected by autoradiography. “−” and “+”
indicate without and with respectively. pS—phosphoserine, pT—phosphothreonine and
pY—phosphotyrosine. Experiment was repeated three times.
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mercaptoethanol, 10% glycerol) for 15 min and subsequently overlaid
on 16% SDS-PAGE for second dimension run. SDS-PAGEwas performed
at a constant voltage of 100 V until the bromophenol blue reached the
bottom of the gels. Subsequently, proteins were transferred to
nitrocellulose membrane, and analyzed by Western immunoblot
using anti-phosphotyrosine antibody and detected with ECL system.
2.10. Phosphoamino acid analysis
C2C12 cells were metabolically labeled with 32P-orthophosphate
(1 mCi/ml, Perkin Elmer Life Sciences, USA) and cell lysates were
prepared as described earlier. PHB was immunoprecipitated as
described above and analyzed by SDS-PAGE and transferred to the
membrane. PHB band was excised after Coomassie staining and
subjected to limited hydrolysis in 6 N HCl at 100 °C for 30 min. TheTable 1
Summary of reports on phosphorylation of prohibitins.
Context or cell/tissue Protein Phosphorylation site(s) Know
C2C12, RINm5F, 3T3 PHB Tyr114, Tyr259 Recep
MiaPaCa-2 PHB Thr258 Akt/P
T cells PHB Ser (speciﬁc site not known) Not id
T cells PHB2 Ser (speciﬁc site not known), Tyr248 Not id
Phosphotyrosine proﬁling in
lung cancer cells
PHB Tyr249 Not id
Phosphotyrosine proﬁling in
lung cancer cells
PHB2 Tyr128 Not id
Cell death and resistance
(Oryza sativa)
PHB Not identiﬁed Not id
Granulosa cells PHB Not identiﬁed Not idsamples were dried and resuspended in buffer (pH 1.9) containing
1 μg of phosphoamino acid standards (Sigma) and analyzed by thin
layer cellulose acetate chromatography (17). Standards were visua-
lized using ninhydrin and 32P-labeled samples were detected by
autoradiography.3. Results and discussion
3.1. Tyrosine phosphorylation of PHB
Phosphorylation of PHB has been suspected earlier due to its
different migration pattern on two-dimensional gel electrophoresis
under different experimental conditions [10–12] suggestive of a
potential role for it in the regulation of various functions of PHB.
Recently PHB has been shown to be required for the Ras-induced Raf-
MEK-ERK activation [18]. Several growth factors elicit their growth
promoting signals primarily through activation of Ras proteinwhich is
crucial for several signaling functions. PHB has been reported to be
present in different cellular compartments in various cells and tissue
types [3–6]. In Caco-2 (a model intestinal epithelial cell) and 3T3-L1
cells PHB and PHB2 were found enriched in lipid rafts, sites that are
believed to regulate many intracellular signaling events [8]. Signaling
cascade starting from IgM receptor is very similar to signaling cascade
initiated by several growth factors including EGF and insulin family
members. Phosphorylation and de-phosphorylation of several signal-
ing intermediates are very important regulatory mechanisms in these
signaling cascades [19]. Therefore, in the present study we have
explored whether PHB is also phosphorylated in response to an
upstream stimulus.
PHB runs at ∼30 kDa on a reducing SDS-PAGE and the entire
protein contains 17 serine, 14 threonine and 4 tyrosine residues which
could serve as phosphorylation sites. To limit the total number of
residues under consideration and increase the probability of uniquely
identifying phosphorylation sites, we immunoprecipitated PHB from
C2C12 cells after insulin stimulation and analyzed with SDS-PAGE and
subsequently with phosphoamino speciﬁc antibodies to determine
whether the phosphorylation sites are phospho-Ser, -Thr or -Tyr
residues. Phosphoamino speciﬁc immunoblot revealed that insulin
stimulation resulted in tyrosine phosphorylation of PHB (Fig. 1).
Similar results were obtained with MCF-7 cells (data not shown).
Membranes were reprobed with anti-PHB antibody to conﬁrm that
the identiﬁed tyrosine phosphorylated band is PHB (Fig. 1). No PHB
band was observed with anti-phosphoserine and anti-phosphothreo-
nine antibodies (data not shown) suggesting that insulin induced
phosphorylation of PHB occurs only at tyrosine residues. Nevertheless
phosphorylation at serine and/or threonine residues may not be ruled
out because speciﬁcity of anti-phosphoserine and anti-phosphothreo-
nine antibodies is not broad like anti-phosphotyrosine antibody.
Therefore, insulin induced tyrosine phosphorylation of PHB was
further conﬁrmed by 32P-orthophosphate labeling and phosphoamino
acid analysis (Fig.1B). Phosphorylation of PHBwas not observed in then/Putative kinase Known/Proposed function Reference
tor tyrosine kinase Cell signaling, protein–protein interaction [26]
KB Regulation of prohibitin function [20]
entiﬁed Mitochondrial homeostasis and survival of T cells [17]
entiﬁed Mitochondrial homeostasis and survival of T cells [17]
entiﬁed Not known [29]
entiﬁed Not known [21]
entiﬁed Defence response and/or programmed cell death [15]
entiﬁed Cell proliferation [12]
Fig. 2. Tyrosine residues in PHB are highly conserved across species. Multiple sequence
alignments of PHB and PHB2 from human, rat, mouse and Drosophila origin. (A)
showing Tyr114 and Tyr259 in PHB are conserved in PHB2 in human, (B) showing all four
tyrosine residues (Tyr28, Tyr114 Tyr249 and Tyr259) in PHB are highly conserved among
different species. Potential tyrosine phosphorylation sites are shown in bold letters.
Fig. 3. Gel electrophoresis analysis of Lys-C digested phosphorylated PHB. In the left
panel, recombinant His-PHB was phosphorylated by insulin receptor (IR) catalytic
domain using 32P-ATP in an in vitro kinase assay and subsequently digested with Lyc-C
as described in Materials and methods. Samples were analyzed with SDS-PAGE and
autoradiography. In the right panel, insulin induced (as described in Fig. 1)
phosphorylated PHB was subjected to in-gel digestion by Lys-C. Subsequently digested
protein samples were electro focused with ampholytes and following the second
dimension tyrosine phosphorylated protein fragments were detected by Western blot
using anti-phosphotyrosine antibody and ECL. Representative blots of 4 experiments
are shown.
1375S.R. Ande et al. / Biochimica et Biophysica Acta 1793 (2009) 1372–1378absence of insulin (Fig. 1B) suggesting that tyrosine phosphorylation
of PHB occurs in an inducible manner.
Recently PHB and PHB2 have been identiﬁed as phospho-proteins
in T lymphocytes by orthophosphate labeling [17]. In this study PHB
was found to be serine phosphorylated and PHB2 to be serine and
tyrosine phosphorylated [17]. Tyrosine phosphorylation of PHB2 was
mapped to Tyr248 which is not conserved in PHB therefore it is not
surprising that PHB was not found to be tyrosine phosphorylated
under experimental conditions used in this study. In a separate study
PHB was identiﬁed as a substrate for Akt and it has been shown that
Akt induced phosphorylation of PHB occurs at Thr258 [20].While these
studies have clearly shown that PHB and PHB2 are phosphorylated at
multiple residues however conditions under which these residues are
phosphorylated and functional consequences are not clear at this time
(Table 1). It is possible that phosphorylation at different residues may
contribute to multiple functions of these two homologous proteins.
3.2. Identiﬁcation of tyrosine phosphorylation site in PHB
Interestingly there are only four tyrosine residues (Tyr28, Tyr114,
Tyr249 and Tyr259) in the entire PHB protein sequence dispersed
throughout the length of PHB molecule from the N-terminus to the C-
terminus. All four tyrosine residues are highly conserved in PHB from
human, rat, mouse and Drosophila origin (Fig. 2). In order to reduce
the size of the protein and therefore number of tyrosine residues to
study the exact site of phosphorylation, we searched for a protease
that would generate PHB fragments: a) which would contain tyrosine
phosphorylation sites, and b) which could be resolved by gelTable 2
Predicted Lys-C cleavage pattern of human PHB.
Position of cleavage site Resulting peptide sequence
4 MAAK
11 VFESIGK
63 FGLALAVAGGVVNSALYNVDAGHRAVIFDRFRGVQDIVVGEGT
83 LIIFDCRSRPRNVPVITGSK
128 DLQNVNITLRILFRPVASQLPRIFTSIGEDYDERVLPSITTEILK
177 SVVARFDAGELITQRELVSRQVSDDLTERAATFGLILDDVSLTHL
186 EFTEAVEAK
202 QVAQQEAERARFVVEK
207 AEQQK
208 K
219 AAIISAEGDSK
240 AAELIANSLATAGDGLIELRK
272 LEAAEDIAYQLSRSRNITYLPAGQSVLLQLPQ
Potential tyrosine phosphorylation sites are shown in bold letters.
TCF—Tyrosine containing fragment.electrophoresis. An analysis of more than 15 protease speciﬁcities
and the resulting digestion patterns (http://ca.expasy.org) suggested
use of endopeptidase Lys-C. Computer simulation of Lys-C digestion
pattern is summarized in Table 2. To conﬁrm Lys-C digestion of PHB as
predicted, recombinant PHB was phosphorylated in an in vitro kinase
assay using IR catalytic domain and subsequently digested with Lys-C.
Analysis of Lys-C digested phosphorylated-PHB by SDS-PAGE and
autoradiography identiﬁed one thick and intense autoradiographic
band at ∼3–5 kDa (Fig. 3). Because the molecular weight of all three
expected tyrosine containing Lys-C digested fragments (TCFs) are
very close to each other (i.e. 5.58, 5.18 and 3.55 kDa, Table 2) it is
possible that this band may contain more than one tyrosine contain-
ing fragment (TCF I–III, Table 2). To investigate whether this band
contain only one or more than one tyrosine containing fragment, we
analyzed insulin induced phosphorylated and Lys-C digested PHB
peptides by 2D-gel electrophoresis and identiﬁed two spots (spot 1
and spot 2) on anti-phosphotyrosine blot (Fig. 3) running around ∼3–
5 kDa as in the case of one-dimensional gel electrophoresis. These two
spots most likely represent two out of three expected Lys-C digested
tyrosine containing fragments (TCF I–III, Table 2) suggesting phos-
phorylation at more than one tyrosine residue (Fig. 3). It is interesting
to note that spot 2 runs slightly lower than spot 1 (Fig. 3) in 2D-gel
electrophoresis that would imply a relatively lower molecular mass
than that of spot 1 andmay be TCF III (peptide mass 3.55 kDa, Table 2)
which contains Tyr249 and Tyr259, and spot 1 which runs slightly
higher than spot 2 may be either TCF I or TCF II (peptide mass 5.58 andPeptide length (AA) Peptide mass (Da) TCF
4 419.54
7 778.90
HFLIPWVQK 52 5581.42 I
20 2271.70
45 5185.99 II
TFGK 49 5392.06
9 1023.10
16 1888.11
5 602.64
1 146.18
11 1061.15
21 2126.43
32 3559.03 III
Fig. 4. In vitro tyrosine phosphorylation of PHB and PHB peptides by active insulin
receptor (IR). (A) In the upper panel, an autoradiograph showing IR induced
phosphorylation of recombinant PHB and PHB peptides. In the lower panel, an anti-
pTyr114 phosphospeciﬁc immunoblot showing IR mediated phosphorylated PHB and
PHB peptides. (B) The stoichiometry of phosphorylation of recombinant PHB and PHB
peptides (PHB107–121 and PHB2121–135) by IR is shown. Experiment was carried out as
described in Materials and methods.
Fig. 5. Shp1 co-immunoprecipitates with insulin induced phosphorylated PHB. PHB
immunoprecipitated from C2C12 cells after treatment with insulin and immunopre-
cipitates were analyzed by immunoblotting using Shp1 antiserum (A, upper panel). In
the lower panel the same membrane was reprobed with PHB antiserum. In (B), pull
down of Shp1 by PHB peptides is shown. In the upper panel, an anti-Shp1 immunoblot
of IR induced phosphorylated PHB peptides mediated pulled down proteins. In the
lower panel, the same membrane was reprobed with streptavidin-HRP conjugate to
show the equal amount of various peptides. (C) Shp1 immunoprecipitated from C2C12
cells after treatment with insulin and immunoprecipitates were analyzed by
immunoblotting using PHB antiserum (upper panel). In the lower panel the same
membrane was reprobed with Shp1 antiserum. “−” and “+” indicate without and with
respectively. Representative blots of three experiments are shown.
1376 S.R. Ande et al. / Biochimica et Biophysica Acta 1793 (2009) 1372–13785.18 kDa, Table 2) containing Tyr28 and Tyr114 respectively. These
results together suggest that there are at least two tyrosine residues
phosphorylated in PHB in response to insulin treatment in C2C12 cells.
To further explore the identity of phosphorylated tyrosine we
analyzed PHB protein sequence using the Human Protein Reference
Database (HPRD) server. Analysis of PHB protein sequence by HPRD
server identiﬁed Tyr114 as insulin and EGF receptors kinase motif. The
same residue was also predicted by NetPhosK 1.0 server as potential
site of phosphorylation by insulin receptor kinase. To conﬁrmwhether
Tyr114 is a direct substrate for insulin receptor kinase, recombinant
PHB protein and synthetic PHB107–121 (Biot-107FTSIGEDYDERVLPS121)
peptide spanning Tyr114 was tested for in vitro kinase assay using
catalytic domain of recombinant insulin receptor (IR) kinase. Tyr114 is
conserved in both PHB and PHB2 and corresponding residue in
PHB2 is Tyr128 (Fig. 2). Therefore a second peptide PHB2121–135
(Biot-121YQRLGLDYEERVLPS135) was also used for an in vitro kinaseassay. Insulin receptor was able to phosphorylate both recombinant
protein as well as peptides (Fig. 4A). In addition to Tyr114, PHB107–121
peptide also contains two serine (Ser109 and Ser121) and one
threonine (Thr108) residues. To get a sense of the number of
residues phosphorylated by IR in full length protein and peptide,
stoichiometry of phosphorylation of recombinant PHB and PHB
peptides by IR was examined (Fig. 4B). Under maximal conditions
∼1.9, 1.02 and 0.98 pmol of 32P was incorporated per pmol of PHB,
PHB107–121 and PHB2121–135 peptides respectively, indicating the
presence of at least two potential IR induced phosphorylation sites
in PHB full length protein and one each in PHB and PHB2 peptides,
which is consistent with the 2D-gel electrophoresis data (Fig. 3). To
make sure phosphorylation occurred at Tyr114 residue membranes
were probed with anti-pTyr114 phosphospeciﬁc antibody. Only
phosphorylated PHB protein and PHB107–121 peptide were detected
by the antibody conﬁrming that phosphorylation occurs at the
Tyr114 residue (Fig. 4A). Interestingly PHB2 peptide which is also
phosphorylated by IR was not recognized by anti-pTyr114 speciﬁc
antibody. One potential reason could be that the immunogen used
to generate pTyr114 speciﬁc antibody differs ∼40% from correspond-
ing peptide in PHB2. A careful search of phosphoprotein database
for any known tyrosine phosphorylation site in PHB and PHB2
revealed that Tyr128 in PHB2 (125GLDpYEERVLPSIVNEVL141) has been
identiﬁed during phosphotyrosine proﬁling of cancer cell proteome
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phosphorylation of PHB and PHB2.
3.3. Co-immunoprecipitation of Shp1 with phosphorylated PHB and
PHB peptide
It is well known that tyrosine phosphorylation by insulin receptor
in many substrates creates phosphotyrosine motifs which facilitate
interaction with other proteins in the signaling cascade or it may
simply alter functional activity of the substrate [13,14]. Therefore we
asked the question whether phosphorylation at Tyr114 in PHB createsFig. 6. Phosphorylation of PHB at Tyr114 is required for its interaction with Shp1. (A)
C2C12 cells were transfected with wild type PHB and Tyr114Phe mutant-PHB (Y11F)
vectors. After 24 h cells were treated with insulin (as described in Fig. 1) and processed
for immunoprecipitation by anti-PHB antiserum. Subsequently samples were analyzed
with anti-Shp1, anti-phosphotyrosine and anti-pTyr114 speciﬁc antibodies (upper
panel). In the lower pane, quantiﬁcation of signal intensities with anti-Shp1 antibody
relative to total PHB is shown. The data represent the mean±SEM for three different
experiments. The signiﬁcant differences are shown. (B) Immunoblots showing
phosphorylation levels of Akt and GSK3β in cells transfected with wild type and
mutant-PHB vectors in response to insulin. Experiment was repeated four times.such phospho motif. Analysis of PHB sequence for phospho motifs
using HPRD server identiﬁed Tyr114 as insulin receptor kinase as well
as Shp1 phosphatase motif. To test whether insulin induced
phosphorylation of PHB in vitro recruit Shp1, pull down assays
were performed. Indeed, biotinylated-PHB107–121 peptide phosphory-
lated at Tyr114 was able to pull down Shp1 in pull down assays
(Fig. 5B). Non-phosphorylated PHB107–121 peptide and phosphory-
lated PHB2121–135 peptide fail to pull down Shp1 (Fig. 5B). Shp1 was
also co-immunoprecipitated with anti-PHB antiserum after insulin
treatment only (Fig. 5A). Similar results were found when co-
immunoprecipitation was performed using anti-Shp1 antibody
(Fig. 5C). To further conﬁrm the phosphorylation of PHB at Tyr114
and its role in interaction with Shp1, Tyr114 was substituted with
phenyl alanine (Tyr114Phe) by site-directed mutagenesis. This
resulted in a signiﬁcant decrease in tyrosine phosphorylation of
PHB suggesting that Tyr114 is the major site for phosphorylation in
PHB in response to insulin (Fig. 6A). Alternatively it is possible that
phosphorylation at Tyr114 has a priming effect on phosphorylation of
other tyrosine residues. To verify that Tyr114 is phosphorylated in
response to insulin, membranes were probed with a phosphorylation
site speciﬁc antibody that speciﬁcally recognizes phosphorylated
Tyr114. Both, endogenous as well as wild type PHB were recognized
by anti-pTyr114 antibody in cell treated with insulin which is
signiﬁcantly reduced in cells over expressing Tyr114Phe mutant-
PHB (Fig. 6A). A weak signal was observed in mutant-PHB lane only
after longer exposure of the ﬁlm. Next, co-immunoprecipitation was
performed after transfecting cells with wild type and mutant-PHB
vectors. Again Shp1 co-immunoprecipitated with endogenous and
wild type PHB after insulin stimulation. Interestingly Shp1 failed to
co-immunoprecipitated in the case of Tyr114Phe mutant-PHB in
comparison to endogenous PHB (vector control) (Fig. 6A). This may
be due to the fact that the molar concentration of mutant-PHB in cell
lysates is higher than endogenous PHB which might compete with
endogenous PHB in binding with anti-PHB antibodies during
immunoprecipitation, and in turn contribute to loss of Shp1 co-
immunoprecipitation. Alternatively it is possible that over expression
of mutant-PHB have attenuated interaction of endogenous PHB with
Shp1. In the absence of insulin stimulation no interaction was
observed between PHB and Shp1 (Figs. 5A, C and 6A) suggesting that
phosphorylation of Tyr114 is required for its interaction with Shp1.
Although corresponding tyrosine residue is conserved in PHB2 and
has been identiﬁed to be phosphorylated at Tyr128 during phospho-
tyrosine proﬁling [21] failed to co-immunoprecipitate Shp1. This may
be due to the fact that adjacent glutamic acid residue (Glu112, on the
N-terminus side of Tyr114) in PHB which constitutes the Shp1 binding
motif is not conserved in PHB2 (Fig. 2A).3.4. Enhanced Akt and GSK3β phosphorylation in cells transfected
with Tyr114Phe mutant-PHB
Shp1 isoform Shp2 is known to play an important role in insulin
signaling pathway upstream of Akt. Since Akt is activated by
phosphorylation at Thr308 and Ser473 at the plasma membrane [22],
we sought to know whether over expression of PHB has any effect on
Akt phosphorylation and activation. Overexpression of wild type PHB
resulted in attenuation of Akt phosphorylation at Thr308 as well as
Ser473 in response to insulin while overexpression of Tyr114Phe
mutant-PHB led to up regulation of Akt phosphorylation at both sites
(Fig. 6B). GSK-3β is one of the well characterized downstream targets
for Akt and it is known that Akt induced phosphorylation of GSK-3β at
Ser9 alters its activity [22]. Therefore, next we examined the Ser9
phosphorylation level of GSK-3β in cells transfected with wild type
and mutant-PHB vectors in response to insulin. Similar to Akt
phosphorylation pattern, an up regulation of GSK-3β phosphorylation
was observed in cells transfected with mutant-PHB in comparison to
1378 S.R. Ande et al. / Biochimica et Biophysica Acta 1793 (2009) 1372–1378wild type PHB (Fig. 6B). These data together suggest that phosphor-
ylation of PHB at Tyr114 may play a role in insulin signaling.
Recently PHB has been shown to interact with membrane phospho-
lipids cardiolipin and phosphatidylethanolamine [23], whether PHB can
also interactwithphosphatidylinositides is not known. In this regard it is
interesting to note that enzyme O-GlcNAc transferase which is
responsible for O-GlcNAc modiﬁcation of a number of insulin signaling
intermediates is shown to be phosphorylated by insulin receptor [24]
and interacts with phosphoinositides [25] and contains tyrosine motifs
similar to PHB [26]. Furthermorewehave shown that PHB interactswith
O-GlcNAc transferase and loss of tyrosinephosphorylationof PHBaffects
tyrosine phosphorylation and activity of O-GlcNAc transferase [26]. This
would imply that PHBmay be part of a protein complex which contains
O-GlcNAc transferase, phosphatase, kinase and phosphoinositides. It is
possible that insulin induced tyrosine phosphorylation of PHB and
subsequent recruitment of tyrosine phosphatase Shp1 may modulate
IRS1 and/or PI3 kinase activity and subsequently downstream signaling.
Our data on changes inAkt phosphorylation and activity in relationwith
phosphorylation status of PHB at Tyr114 support this hypothesis that
warrant further investigation.
Recently PHB has been identiﬁed as a substrate for Akt and it has
been shown that Akt induced phosphorylation of PHB occurs at Thr258
which is present within Akt consensus motif 254Arg-Ser-Arg-Asn-Ile-
Thr258 (R-x-R-x-x-S/T) [20]. Interestingly Tyr259 in PHB is present at
tandem position from Akt motif and recently we have shown that PHB
is also phosphorylated at this residue in response to insulin [26]. It is
possible that phosphorylation of PHB at Thr258 by Akt and at Tyr259 by
insulin receptor or other tyrosine kinases may affect each other and
may have two opposing effects on insulin or other signaling pathway.
In addition to Tyr114 which is identiﬁed as insulin receptor kinase
motif as well as tyrosine phosphatase binding motif by HPRD, Tyr259
was also identiﬁed as an FRIB phosphotyrosine binding (PTB) motif by
HPRD. FRIB is a hematopoietic cell-speciﬁc rasGAP interacting protein
which undergoes phosphorylation at PTB motif in response to
cytokine stimulation, and may negatively regulate proliferation by
acting as an adapter molecule between rasGAP and receptor
complexes [27]. Tyr259 in PHB is also conserved among human, rat,
mouse and Drosophila (Fig. 2). A similar motif is a characteristic
feature of expending family of immune inhibitory receptors and plays
an important role in inhibition of B cell proliferation [28]. PHB (also
known as BAP 32) and PHB2 (also known as BAP 37) have been
reported to be present in association with IgM receptor [3]. It is
possible that PHB has a previously unrecognized role in signal
transduction through IgM receptor and immune inhibitory receptors
through tyrosine phosphorylation in response to various upstream
stimuli. PHB may have an analogous role in signal transduction
through insulin, EGF and other growth factor receptors.
In summary, we have provided substantive evidence for tyrosine
phosphorylation of PHB by insulin and have identiﬁed Tyr114 as an
important phosphorylation site in PHB. We have also showed that
phosphorylation at Tyr114 in response to insulin stimulation recruits
Shp1 and alters phosphorylation of Akt and GSK3β indicating a
potential role in insulin signaling pathway and warrants further
investigation.
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